Clinical Research

Mayo Clinic develops AI capable of substantially improving dementia diagnoses
With the software's help, readers are up to three times more accurate and interpretations are nearly twice as fast.
AI helps spot fatty liver disease on routine radiographs
If left undiagnosed and untreated for a prolonged period, fatty liver disease can progress to more serious conditions, such as cirrhosis and liver cancer.
How anti-DEI healthcare policies are impacting patient care
All over the United States, countless research projects designed to improve outcomes have lost funding or been shut down. Even screening efforts targeting patients in impoverished communities have been impacted by these policies.
First 250 patients enrolled in transcatheter heart failure device trial to reduce LV size
The first 250 patients has been enrolled in the CORCINCH-HF U.S. pivotal trial evaluating the AccuCinch Transcatheter Left Ventricular Restoration System in patients with HFrEF.
Shoulder ultrasound effectively detects insulin resistance, even before abnormal labs
POCUS could represent a quick, easy and affordable way to detect signs of insulin resistance before it progresses into diabetes, researchers suggest.

An 86-year-old patient is showing signs of improvement six months after receiving the world’s first implant of a new-look medical device for treating tricuspid regurgitation (TR), according to new data published in JACC: Cardiovascular Interventions.[1] The device in question, the Tricuspid Flow Optimizer, was developed by Triflo Cardiovascular, a U.S.-based biomedical company founded in 2017 by a team of structural heart specialists.

Cardiologists share update after world’s first implant of new optimizer device for tricuspid regurgitation

The Tricuspid Flow Optimizer was developed by Triflo Cardiovascular, a U.S.-based healthcare technology company founded by structural heart specialists.

Could diamond dust replace gadolinium in MRI contrast agents?

An accidental discovery could have future implications for the material makeup for MRI contrast media.

Statin therapy may help HFpEF patients lower their risk of death, heart attack or stroke

All participants were free of ASCVD and had no history of statin use at the start of the study.

New PET technique spots 'smoldering' changes not visible on MRI in the brains of MS patients

The new technique uncovers hidden inflammation in patients who, despite undergoing extensive treatment for the condition, had worsening symptoms.

old elderly couple coffee drink retired love romance man

TAVR, SAVR linked to similar QOL improvements for intermediate-risk patients after five years

TAVR was initially associated with greater benefits than surgery, but that difference faded by the end of the first year.

Rad techs helpfully ‘stand in a surgeon’s shoes’ thanks to virtual reality

Johns Hopkins researchers demonstrated the worthiness of the concept this year.

Video of James Januzzi explaining the results of a new diabetic cardiomyopathy treatment in ACC 2024 late-breaking ARISE-HF trial. #ACC #ACC24 #ACC2024

Diabetic cardiomyopathy treatment shows promise in ARISE-HF

James Januzzi Jr., MD, said the treatment's overall impact was neutral, but he and his team saw "a very clear and encouraging signal."

Alzheimer’s imaging experts to assess utility, efficiency of Hyperfine’s Swoop system

Is portable MRI suitable for finding abnormalities in the brains of patients receiving new amyloid-targeting therapy for Alzheimer’s disease? Clinical researchers are about to find out.

Clinical Research

Mayo Clinic develops AI capable of substantially improving dementia diagnoses

AI helps spot fatty liver disease on routine radiographs

How anti-DEI healthcare policies are impacting patient care

First 250 patients enrolled in transcatheter heart failure device trial to reduce LV size

Shoulder ultrasound effectively detects insulin resistance, even before abnormal labs